Teva launches generic version of EpiPen for kids

Alia Paavola - Print  | 

Teva Pharmaceuticals has launched its generic version of Mylan's EpiPen Jr., the lifesaving allergy treatment for young children.

The generic EpiPen Jr. auto-injector will be available in most retail pharmacies across the U.S. at a price of $300 for a two-pack.

Teva already launched the EpiPen generic for adults after securing FDA approval on the product last August.

There has been a shortage of EpiPens in the U.S. and Mylan warned in June it expects shortages to continue.

More articles on pharmacy:
CMS to cover CAR-T therapy nationwide
Colombia fines Pfizer $25K for drug price inflation
Jefferson Healthcare opens retail specialty pharmacy

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.